Submission Details
| 510(k) Number | K860525 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 11, 1986 |
| Decision Date | April 11, 1986 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
K860525 is an FDA 510(k) clearance for the ABUSCREEN RADIOIMMUNOASSAY FOR LSD W/ REF STANDARD, a Radioimmunoassay, Lsd (125-i) (Class II — Special Controls, product code DLB), submitted by Roche Diagnostic Systems, Inc. (Nutley, US). The FDA issued a Cleared decision on April 11, 1986, 59 days after receiving the submission on February 11, 1986. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3580.
| 510(k) Number | K860525 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 11, 1986 |
| Decision Date | April 11, 1986 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
| Product Code | DLB — Radioimmunoassay, Lsd (125-i) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3580 |